GSK launches $50M bioelectronics venture fund

08/8/2013 | Reuters

GlaxoSmithKline launched a $50 million strategic venture capital fund to further the development of so-called bioelectronics or electroceuticals, which use electrical impulses rather than chemicals or biological molecules to treat disease. Ultimately, nanoscale implants could be developed to encourage insulin production, correct muscle imbalances or regulate food consumption, for example.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ